secwatch.observer — SEC 8-K summary
======================================

Issuer:     IDEAYA Biosciences, Inc. (IDYA)
CIK:        0001676725
Form:       8-K
Filed at:   2023-07-03T23:59:59+00:00
Accession:  0001193125-23-181337
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

IDEAYA Biosciences appoints Andres Ruiz Briseno as Principal Accounting Officer
-------------------------------------------------------------------------------

- Andres Ruiz Briseno appointed Principal Accounting Officer, effective July 1, 2023, and promoted to SVP, Head of Finance and Investor Relations.
- Mr. Briseno brings over 10 years of finance experience, previously Senior VP at Neumora Therapeutics, and earlier roles at Pharmacyclics.
- Received option to purchase 22,500 shares at exercise price $23.23 (closing price on June 29, 2023).
- Amended employment agreement includes base salary, target cash incentive, and severance benefits; summary to be filed in Q2 2023 10-Q.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676725/000119312523181337/0001193125-23-181337-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676725/000119312523181337/d524590d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-181337

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer